Life Science ‘The Funding Journey’

Medilink is hosting a funding workshop in collaboration with Northern Powerhouse to give you an overview of the funding available for the health and life sciences sector. The event will be held on the 3rd of October at KPMG LLP (UK) in Leeds.

Chaired by Sir John Burn*, this event provides life science companies with all they need to take a hold of the funding journey from early stage proof of concept grants to equity and floating on AIM.

In addition to top professionals from funding agencies, Business Angel Groups, Fund Managers, VCs and IPO specsuccessfialists, you will hear from CEOs and entrepreneurs who have successfully secured grants and investment in the past, and are prepared to share their experience with you.

Among the speakers at the event are Matt Chapman, lead on Medical Technology within the Health team at Innovate UK’s Knowledge Transfer Network and Martin Avison Managing Director, Angel Groups, Financial Pulse Limited.

The workshop will also feature a panel of senior representatives from companies that haveully secured various types of funding in the past, will share their real world experiences through questions posed by the chair and the audience.

Whether you are a CEO/CFO/CTO or COO you will meet a remarkable range of experts under one roof to take you through the funding journey from early stage proof of concept grant funding to equity and IPO.

*Sir John Burn is a Professor of Clinical Genetics and Consultant at Newcastle, Chairman of QuantuMDx and non-Executive Director of NHS England.

The complete panel is as follows:

Speakers

Sir John Burn - Non Exec Director NHS England, Chair QuantuMDx, Prof Clinical Genetics

Kevin Kiely - CEO, Medilink

Matt Chapman - Innovate UK, KTN Knowledge Transfer Manager - Health

Mark Wilcockson - British Business Bank, NPIF Senior Relationship Manager

Mark Gibbons - NPIF Micro Fund (NW), Business Finance Solutions

Michael Vassallo - Investment Director at Maven Capital Partners

Faisal Dhalla - Partner Hempsons Law

Marco Schwartz - HEad of Equity Capital Markets UK, KPMG

Chris Warwick - Analyst, Health Enterprise

Martin Avison - Managing Director, Angel Groups, Financial Pulse Limited

Barry James - Managing Director, The Crowdfunding Centre

Peter Dines - Investment Director, Head of Life Sciences, Mercia Technologies PLC

Warren Taylor - Partner, CMS

Insight Panel

Rich Mills - CEO Braintrain 20:20 Ltd

Kadem Al-Lamee - CEO Arterius Ltd

Matthew Tulley - Founder & former CEO Single Use Surgical

Sam Whitehouse - CTO QuantuMDx

Juliana Haggerty - Proposal Development Manager Centre for Process Innovation

Gordon Barker - CEO MicroBioSensors

Date: October 3

Time: 9:00 am - 5:00 pm

Venue: KPMG LLP, 1 Sovereign Street, Leeds, LS1 4DA

Cost: Members - £45 (£35 for 2nd & 3rd places), Non Members - £95 (£70 for 2nd & 3rd places)

Please click here to book your place today.

Please click here to read the event literature for more detail.

If you have any further queries, please email connect@medilink.co.uk . #Medilink20

 

Comments are closed.